Planning Grant for Global Infectious Disease Research Training Program (D71 No Clinical Trials Allowed) | PAR 19 362

Opportunity Information: Apply for PAR 19 362

The National Institutes of Health (NIH) funding opportunity PAR-19-362, titled "Planning Grant for Global Infectious Disease Research Training Program (D71 No Clinical Trials Allowed)," supports low- and middle-income country (LMIC) institutions that want to build a new, locally anchored infectious disease research training program in partnership with U.S. collaborators. The grant is specifically a planning award, meaning it is meant to help an LMIC institution design and prepare for a future full-scale training program rather than immediately operating a large training pipeline. The overall aim is capacity-building: strengthening the LMIC institution so it can lead and sustain high-quality infectious disease research training that responds to major public health needs in its setting.

The FOA emphasizes two main deliverables. First, applicants are expected to lay out a structured, collaborative planning process for designing a Global Infectious Disease (GID) research training program. This planning should be done in active collaboration with U.S.-based partners, with clear roles and a process that results in a coherent program design rather than a loose set of ideas. Second, the planning period must be used to strengthen LMIC faculty and institutional readiness. That includes developing faculty leadership and technical skills and creating advanced didactic coursework, research methodology training materials, and other training resources that will be used once the envisioned program launches. In other words, the grant supports both the blueprint for the future program and the foundational investments needed to make that program credible and sustainable.

Programmatically, NIH is looking for a well-developed vision centered on infectious diseases that are especially relevant to LMICs. The proposed training program concept should focus on at least one major endemic disease, life-threatening emerging infectious disease, neglected tropical disease, infections that commonly occur as co-infections among people living with HIV, or infectious conditions linked with non-communicable diseases that have important public health impacts in LMIC contexts. The intent is to ensure the resulting training program aligns with real disease burdens and builds research expertise where it is most urgently needed.

This opportunity is limited to non-U.S. applicant institutions. Eligible applicants include non-domestic (non-U.S.) entities and foreign institutions based in LMICs. A key restriction is that non-domestic components of U.S. organizations are not eligible to apply, which reinforces that the applicant and primary institutional home for the planned training program must be based outside the United States. The activity category is health, the funding mechanism is a grant, and the CFDA listing provided is 93.989.

Funding details in the source information indicate an award ceiling of $100,000. The posting lists an original closing date of 2022-10-28 and a creation date of 2019-09-03. As written in the title, clinical trials are not allowed under this FOA, so proposed activities should remain focused on training-program planning, curriculum and resource development, faculty strengthening, and other preparatory work that does not involve conducting clinical trial research.

In practical terms, a strong application under this FOA would read like a disciplined start-up plan for a new research training program: a needs assessment tied to local and regional infectious disease priorities, a plan for how LMIC and U.S. collaborators will co-design the program, a faculty development strategy that leaves the LMIC institution with stronger leadership and mentorship capacity, and concrete outputs like advanced courses, research methods modules, mentorship structures, and training resources that can be deployed in a later implementation phase. The end goal is an LMIC-led training program design that is ready to compete for larger support and is positioned to grow the next generation of infectious disease researchers in the applicant country or region.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Planning Grant for Global Infectious Disease Research Training Program (D71 No Clinical Trials Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.989.
• This funding opportunity was created on 2019-09-03.
• Applicants must submit their applications by 2022-10-28. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $100,000.00 in funding.
• Eligible applicants include: Others.

Apply for PAR 19 362

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: